Virtual Incision is pioneering the field of robotic-assisted surgery with its innovative Miniaturized Robotic-Assisted Surgery (miniRAS) system, known as MIRA. This groundbreaking technology is designed to enhance surgical precision through smaller incisions, which can lead to fewer complications, shorter hospital stays, and a reduced need for conversions to open surgery. The miniRAS system aims to address the accessibility challenges associated with traditional robotic-assisted surgery by offering a more compact and user-friendly design that can be integrated into existing hospital infrastructures. This approach not only facilitates more surgeries per day but also expands the reach of robotic surgery to a greater number of patients and healthcare facilities.

The MIRA system's design emphasizes a tray-to-table concept, which is intended to streamline the surgical process and make robotic-assisted surgery more feasible for a wider range of medical environments. By focusing on miniaturization, Virtual Incision seeks to democratize access to advanced surgical techniques, ensuring that the benefits of robotic surgery are available to more patients. The company's commitment to clinical excellence and continuous improvement underpins its mission to transform the landscape of surgical care through innovative technology.

United States

Virtual Incision is on a mission to simplify robotic-assisted surgery (RAS), so more patients and their surgeons can access its benefits every day.

Headquartered in Lincoln, Nebraska, and holding over 200 patents and patent applications, the company is developing MIRA, the first-of-its-kind miniature, and highly accessible RAS platform. With MIRA, our goal is to make every operating room RAS-ready.

MIRA is currently in FDA clinical trials under an Investigational Device Exemption (IDE) and is being studied first for bowel resection, with additional potential applications to follow.

https://virtualincision.com

Virtual Incision

Company Details